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ABSTRACT Bloodstream infections are a leading cause of morbidity and mortality
in the United States and are associated with increased health care costs. We evalu-
ated the Portrait Staph ID/R blood culture panel (BCP) multiplex PCR assay (Great
Basin Scientific, Salt Lake City, UT) for the rapid and simultaneous identification (ID)
of Staphylococcus aureus, Staphylococcus lugdunensis, and Staphylococcus species to
the genus level and the detection of the mecA gene directly from a positive blood
culture bottle. A total of 765 Bactec bottles demonstrating Gram-positive cocci in
singles or clusters were tested during the prospective trial at 3 clinical sites. The Por-
trait Staph ID/R BCP results were compared with results from conventional bio-
chemical and cefoxitin disk methods performed at an independent laboratory. Dis-
cordant ID and mecA results were resolved by rpoB gene sequencing and mecA
gene sequencing, respectively. A total of 658 Staphylococcus species isolates (S. au-
reus, 211 isolates; S. lugdunensis, 3 isolates; and Staphylococcus spp., 444 isolates)
were recovered from monomicrobial and 33 polymicrobial blood cultures. After dis-
crepant analysis, the overall ratios of Portrait Staph ID/R BCP positive percent agree-
ment and negative percent agreement were 99.4%/99.9% for Staphylococcus ID and
99.7%/99.2% for mecA detection.
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Despite advances in medical practices, bloodstream infections (BSIs) remain asignificant cause of death in the United States. In the United States, sepsis is the
leading cause of death among critically ill patients in noncoronary intensive care units
(ICUs) and is the 10th leading cause of death overall, with the cost of care exceeding
$17 billion annually (1). Gram-positive organisms as a cause of sepsis are now more
common than Gram-negative infections (2). The staphylococci are a major cause of
hospital- and community-acquired infections, leading to serious infections associated
with significant rates of morbidity and mortality (3). A study that included 49 U.S.
hospitals revealed that the incidence rates and distribution of monomicrobial BSIs for
coagulase-negative staphylococci (CoNS) and Staphylococcus aureus comprised approx-
imately one-third and one-fifth of the total cases, respectively (4). In addition, the
mortality rates for infections by these two pathogens totaled approximately 20% and
25%, respectively (4).
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Currently, blood cultures continue to be the standard method for diagnosing BSIs
(5). This conventional method requires additional testing in vitro to identify the
organism and obtain an antimicrobial susceptibility profile. Thus, results will not be
available to the physician until 2 to 3 days from the moment the blood culture is
identified as positive. The availability of rapid detection of such pathogens is necessary
to decrease the time between detection and treatment. This is of utmost importance,
as it has been shown that mortality increases with each day of inappropriate treatment
(6).
The Portrait Staph ID/R blood culture panel (BCP) is a qualitative, multiplex, nucleic
acid-based assay that simultaneously identifies Staphylococcus aureus, Staphylococcus
lugdunensis, and various Staphylococcus species to the genus level and detects the
mecA gene, the primary determinant of methicillin resistance, directly from positive
blood cultures. The test utilizes automated hot-start-enabled PCR for amplification of
specific DNA targets detected by hybridization probes immobilized on a silicon chip
surface. The Great Basin PA500 Portrait system is a fully automated system that includes
the Portrait Analyzer, single-use Staph ID/R BCP cartridges, and the Portrait data
analysis software. The Portrait system is designed to perform automated sample
preparation, PCR, and optimal chip-based detection with integrated data analysis in 110
min.
The purpose of this multicenter study was to assess the performance of the Portrait
Staph ID/R BCP compared to conventional methods.
(This study was presented in part at the American Society of Microbiology Microbe
2016 Meeting, Boston, MA, 20 June 2016.)
RESULTS
The clinical performances of Portrait Staph ID/R BCP and of conventional methods
for the identification of Staphylococcus species and detection of mecA are summarized
in Tables 1 and 2, respectively. A total of 765 mono- and polymicrobial prospective
blood cultures meeting the criteria for inclusion were included in the clinical trial. The
Portrait Staph ID/R BCP identified S. aureus (211 isolates), S. lugdunensis (3 isolates), and
TABLE 1 Summary of the clinical performance of Portrait Staph ID/R BCP versus
conventional methods for the identification of Staphylococcus species in 765 prospective
blood culturesa
Organism(s) identified
(all sites combined)
% Agreement
TP/TP  FN PPA (95% CI) TN/TN  FP NPA (95% CI)
S. aureus 211/214 98.6 (96.0–99.5) 549/551 99.6 (98.7–99.9)
S. lugdunensis 3/3 100 (43.9–100) 761/762 99.9 (99.3–99.9)
Staphylococcus species
other than S. aureus
or S. lugdunensis
444/449 98.9 (97.4–99.5) 311/313 99.4 (97.7–99.9)
aTP, true positive; TN, true negative; FP, false positive; FN, false negative; PPA, positive percent agreement;
NPA, negative percent agreement; CI, confidence interval.
TABLE 2 Summary of the clinical performance of Portrait Staph ID/R BCP versus cefoxitin
disk diffusion test method for the detection of methicillin resistance in 762 prospective
blood culturesa
Result, all sites combined, for
detection of methicillin
resistance
% Agreement
TP/TP  FN PPA (95% CI) TN/TN  FP NPA (95% CI)
S. aureus 72/75 96.0 (86.6–97.8) 682/687 99.3 (98.3–99.7)
S. lugdunensis 0/0 NA 762/762 100 (99.5–100)
Staphylococcus spp. other than
S. aureus or S. lugdunensis
247/263 93.9 (90.3–96.2) 481/499 96.4 (94.4–97.7)
aThree culture isolates of Staphylococcus failed to grow on Mueller-Hinton agar for cefoxitin testing. TP, true
positive; TN, true negative; FP, false positive; FN, false negative; PPA, positive percent agreement; NPA,
negative percent agreement; CI, confidence interval. NA, not applicable.
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Staphylococcus species other than S. aureus or S. lugdunensis (444 isolates) with positive
percent agreement (PPA) of 98.6%, 100%, and 98.9% and negative percent agreement
(NPA) of 99.6%, 99.9%, and 99.4%, respectively (Table 1). Overall, there were 13
discordant species in identification with the Staph ID/R BCP and the BD Phoenix
conventional method (Table 3). Of the 13 discordant results called, 8 were false positive
(FP) and 5 were false negative (FN). When the 13 discordant specimens were tested by
rpoB sequencing, 7 results were in agreement with Portrait Staph ID/R BCP (Table 3).
After discrepant analysis, the overall Portrait Staph ID/R BCP PPA and NPA for Staph-
ylococcus ID increased from 98.8% and 99.7%, respectively, to 99.4% and 99.9%.
The Portrait Staph ID/R BCP detected mecA in S. aureus (69 isolates) and Staphylo-
coccus species other than S. aureus or S. lugdunensis (243 isolates) with PPA of 96.0%
and 93.9% and NPA of 99.3% and 96.4%, respectively (Table 2). Three culture isolates
of Staphylococcus failed to grow on Mueller-Hinton agar for cefoxitin, resulting in 762
blood cultures tested. Overall there were 42 discordant mecA detection results com-
pared to cefoxitin disk diffusion (23 FP and 19 FN), irrespective of species identification.
For 24/41 discordant specimens, mecA sequencing results were concordant with the
Portrait Staph ID/R BCP. One specimen was not subjected to discordant analysis. The
remaining 16/41 specimens consisted of 15 FP and 1 FN mecA sequencing results.
A total of 2.3% (18/765) polymicrobial blood culture specimens were examined by
Portrait Staph ID/R BCP and conventional methods (Table 4). Conventional cultures
accounted for 1.7% (13/765) of the polymicrobial specimens during the study, with 33
isolates recovered. The Portrait Staph ID/R BCP “mixed Staph” infections accounted for
0.5% (4/765) of the polymicrobial specimens, and 1 of 765 specimens (0.1%) was
polymicrobial for both Portrait Staph ID/R BCP and conventional cultures. When
specimens with conventional polymicrobial results were compared to the Portrait
Staph ID/R BCP, a single FN result for S. aureus and two FN mecA results were obtained
by Staph ID/R BCP. In four specimens with Portrait Staph ID/R BCP in mixed infections,
three were FP for S. aureus compared to culture and one specimen was correct for S.
aureus but FP for mixed Staphylococcus infection and mecA. Polymicrobial results by
both Portrait Staph ID/R BCP and conventional methods displayed complete agreement
in one specimen.
The overall initial invalid result rate in this prospective study was 1.39%. The overall
aborted run or “test incomplete” rate was 3.30%. Valid results were achieved after
retesting all invalid-result and test-incomplete runs.
TABLE 3 Staphylococcus species identification discordant sequencing results for rpoB (all sites combined)
Portrait Staph ID/R BCP result Discordant result (n)b BD Phoenix result rpoB sequencing result
S. aureus in mixed Stapha infection
(not S. lugdunensis)
FP for mixed (1) S. aureus S. aureus
S. aureus in mixed Staph infection (not
S. lugdunensis)
FP (1) Staphylococcus epidermidis S. epidermidis
S. aureus in mixed Staph infection (not
S. lugdunensis)
FP (1) Staphylococcus hominis S. hominis
S. lugdunensis in mixed Staph infection
(not S. aureus)
FP (1) S. epidermidis S. epidermidis
Staph species other than S. aureus or
S. lugdunensis
FP (2) Corynebacterium jeikeium Staphylococcus pettenkoferi
Staph species other than S. aureus or
S. lugdunensis
FP (1) Rothia mucilaginosa S. epidermidis
Staph species other than S. aureus or
S. lugdunensis
FP (1) R. mucilaginosa/Streptococcus gordonii S. hominis/S. epidermidis
Staph species other than S. aureus or
S. lugdunensis
FN (2) S. aureus S. epidermidis
Staph species other than S. aureus or
S. lugdunensis
FN (1) S. aureus/S. epidermidis/S. hominis S. epidermidis
Negative FN (1) S. epidermidis S. epidermidis
Negative FN (1) S. hominis S. epidermidis
amixed Staph, mixed Staphylococcus spp.
bFor a total of 13 isolates; FP, false positive; FN, false negative.
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Various Bactec bottle types were evaluated in this study. The most frequent Bactec
bottle type used in this study was Bactec Plus Aerobic/F (n  333), followed by Bactec
Standard/10 Aerobic/F (n  182), with the Bactec Lytic/10 Anaerobic/F medium (n 
77), Bactec Plus Anaerobic/F medium (n  11), and Bactec Standard/10 Anaerobic/F
medium (n  90) being used less. The Bactec Peds Plus/F medium (BD) was also tested
(n  62). The blood culture bottle types used in the study did not display any apparent
performance difference (data not shown).
DISCUSSION
Staphylococcal species are the leading cause of BSIs worldwide, and up to 60% of
all staphylococcal infections are methicillin resistant. Staphylococcus aureus is the most
common pathogen found in positive blood cultures, with a high prevalence of
methicillin-resistant S. aureus (MRSA). Patients with MRSA bacteremia have demon-
strated a higher mortality rate than those with methicillin-susceptible S. aureus (MSSA)
bacteremia (7). The CoNS are common and typically nonthreatening inhabitants of skin
and mucus membranes. However, CoNS can cause human infections that characteris-
TABLE 4 Performance of Portrait Staph ID/R BCP and/or conventional methods for polymicrobial specimensa
Staph ID/R species ID, mecA results Conventional method species ID, cefoxitin susceptibility results
Discrepant result
Species ID mecA
Polymicrobial specimens for conventional methods
Staph species other than S. aureus
or S. lugdunensis, mecA absent
S. aureus, sensitive S. epidermidis, not tested S. hominis, not tested FN S. aureus
Staph species other than S. aureus
or S. lugdunensis, mecA absent
S. epidermidis, sensitive S. epidermidis, resistant FN
Staph species other than S. aureus
or S. lugdunensis, mecA absent
S. capitis, sensitive S. pettenkoferi, resistant FN
Staph species other than S. aureus
or S. lugdunensis, mecA absent
S. capitis, sensitive S. epidermidis, no growth
Staph species other than S. aureus
or S. lugdunensis, mecA absent
S. epidermidis, sensitive S. haemolyticus, sensitive
Staph species other than S. aureus
or S. lugdunensis, mecA absent
S. epidermidis, sensitive S. capitis, sensitive
Staph species other than S. aureus
or S. lugdunensis, mecA absent
S. epidermidis, sensitive S. warneri, sensitive
Staph species other than S. aureus
or S. lugdunensis, mecA absent
S. hominis, sensitive S. capitis, sensitive
Staph species other than S. aureus
or S. lugdunensis, mecA present
S. capitis, sensitive S. epidermidis, resistant
Staph species other than S. aureus
or S. lugdunensis, mecA present
S. hominis, resistant S. epidermidis, resistant
Staph species other than S. aureus
or S. lugdunensis, mecA present
S. hominis, resistant S. epidermidis, resistant
Staph species other than S. aureus
or S. lugdunensis, mecA present
S. hominis, resistant S. capitis, sensitive
Staph species other than S. aureus
or S. lugdunensis, mecA present
S. epidermidis, resistant S. haemolyticus, sensitive
Polymicrobial specimens for Staph ID/R BCP in mixed Staphylococcus infections
S. aureus in mixed Staph infection
(not S. lugdunensis), mecA absent
S. epidermidis, sensitive FP S. aureus
S. aureus in mixed Staph infection
(not S. lugdunensis), mecA present
S. hominis, resistant FP S. aureus
S. aureus in mixed Staph infection
(not S. lugdunensis), mecA present
S. aureus, sensitive FP mixed FP
S. aureus in mixed Staph infection
(not S. lugdunensis), mecA present
S. epidermidis, resistant FP S. aureus
Polymicrobial specimens for both Staph ID/R BCP and conventional methods
S. aureus in mixed Staph infection
(not S. lugdunensis), mecA present
S. aureus, sensitive S. epidermidis, resistant
aFN, false negative; FP, false positive; Staph, Staphylococcus.
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tically involve indwelling medical devices. Clinically significant bacteremia caused by
CoNS remains problematic and difficult to interpret (8, 9). Staphylococcus lugdunensis is
a species of CoNS that can cause severe and potentially fatal disease, including vascular
catheter infections, bacteremia, and sepsis (10). Outcome studies have shown that a
single S. lugdunensis-positive blood culture can represent a clinically significant bacte-
remia and should not be classified as a contaminant (11).
The high prevalence of MRSA combined with the slow turnaround time for organism
identity and antibiotic resistance information has led physicians to use empirical
therapy with agents such as vancomycin for suspected staphylococcal infections. It has
been demonstrated elsewhere that up to one-third of all staphylococcal infections are
treated suboptimally due to inappropriate empirical therapy. Schweizer et al. (12)
demonstrated that patients with MSSA bacteremia had significantly lower mortality
when treated with a more appropriate beta-lactam antimicrobial than when treated
with vancomycin. Rapid identification of the causative agent and detection of resis-
tance mechanisms, like the mecA gene in patients with BSIs, can provide the physician
important information to guide appropriate treatment in a timely manner, leading to
improved patient outcomes. Studies using a rapid molecular S. aureus/MRSA test from
positive blood cultures have reduced the time of diagnosis from 24 to 48 h to 1 to 2
h following indication of a blood culture being Gram-positive cocci in singles or clusters
(GPCC) positive, leading to improved patient care, antimicrobial management, length
of patient stay, and hospital costs (6, 13, 14). These methods are most effective when
an active antimicrobial stewardship program is available (15). The impact of rapid
peptide nucleic acid fluorescence in situ hybridization (PNA FISH) testing demonstrated
how excessive vancomycin usage could be prevented for the treatment of CoNS-
contaminated blood cultures (16). In addition, early identification of CoNS in blood
cultures, thus ruling out S. aureus or S. lugdunensis, could avoid unnecessary treatment and
hospital stay for patients found to have a blood culture contaminant. The value of
appropriate therapeutic decisions makes molecular diagnostic tests an attractive alternative
to conventional blood culture methods that can take up to several days to complete.
The Portrait Staph ID/R system is an automated benchtop analyzer with low-cost,
disposable cartridges for performing on-demand testing during any shift. The imme-
diate benefit of the Portrait Staph ID/R system is the minimal sample handling (sample
in/results out). The Portrait Staph ID/R system can be easily integrated into the normal
laboratory workflow, providing decreased time to identification and resistance results.
Invalid and “test incomplete” rates in this study were low, and these issues were
resolved on retesting. In additional analytical studies, Portrait Staph ID/R was shown to
have equivalent performance on Bactec with 6 bottle types, BacT/Alert with 5 bottle
types, and 2 bottle types with Versa Trek blood culture systems (data not shown). The
equivalence in performance across the three major blood culture systems including 13
different bottle types indicates a broad tolerance to medium types.
In this study, there were 42 discordant mecA results compared to the results
obtained by testing of colonies isolated from the positive blood culture using cefoxitin
disk diffusion as the comparator method. False-negative results (n  19) could be
explained by specific mecI-mediated repression of mecA transcription and penicillin
binding protein 2a (PBP 2a) production and derepression of mecA following the
induction by cefoxitin (17). However, only one unresolved falsely negative discordant
mecA result (Portrait Staph ID/R BCP reported the presence of Staphylococcus species
other than S. aureus or S. lugdunensis, mecA negative, in contrast to the conventional
method result) occurred in blood cultures in which a single organism was detected,
This suggests that the Portrait Staph ID/R assay was highly accurate for detecting the
presence of the mecA gene. Interestingly, 15/23 false-positive results were unresolved by
testing of isolates by PCR/mecA gene sequencing, which may point out a limitation of the
study design. In a study evaluating the FilmArray BCID panel (18), overall positive and
negative predictive agreement was determined in comparison to PCR/sequencing of
cultured isolates (99.2% and 86.6%, respectively, for all mecA results combined) and
PCR/sequencing directly from blood cultures (98.4% and 98.0%, respectively). The lower
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negative predictive agreement obtained when performing PCR/sequencing on isolates
than directly from positive blood culture indicates the potential for the presence of multiple
indistinguishable organisms in the blood culture broth with different resistance profiles.
In this study, polymicrobial blood cultures were low, accounting for 1.7% (13/765) by
the reference culture method and 0.5% (4/765) by the Portrait Staph ID/R BCP assay,
although the several cases of unresolved false-positive mecA results suggest an under-
detection of poly-CoNS samples. While the Portrait Staph ID/R BCP can detect mixtures
of S. aureus with CoNS, it cannot detect mixtures containing multiple CoNS species
other than S. lugdunensis. Polymicrobial sepsis is considered uncommon, occurring at
a rate of 4.7% in one series of septic episodes (19). The impact of detecting multiple
CoNS in blood cultures in these cases would be minimal since they would be classified
as probable contaminants.
One limitation of the Portrait Staph ID/R system is that it targets detection of only
staphylococci and mecA. Inclusion of other species-specific targets such as the strep-
tococci and enterococci as well as resistance markers vanA and vanB would enhance
the utility of the Portrait Staph ID/R system for Gram-positive organisms. However, the
typical microbiology laboratory can readily detect the phenotype of Gram-positive
cocci in clusters. With staphylococci being the most prevalent cause of bloodstream
infection seen and the clinical utility of these tests resulting in lower treatment costs
and lengths of stay, a more focused test like this one may have value in the laboratory,
especially at its significantly lower price ($45) than that of a broader panel, priced at $75
to $129 (20, 21). Another potential limitation of PCR diagnostic testing is the emergence
ofmecCMRSA (22). Similar tomecA,mecC is carried on the staphylococcal chromosomal
cassette mec gene that codes for a PBP 2a, which mediates resistance to beta-lactam
antibiotics. Although mecC MRSA is currently extremely rare, the possibility exists that
mecA MRSA assays will fail to detect isolates that contain mecC. Finally, the Portrait
Staph ID/R system does not replace conventional identification and antimicrobial
susceptibility testing. Supplemental testing contributes to additional expense to the
laboratory budget.
In conclusion, the performance of the Portrait Staph ID/R BCP in this study was
found to be highly favorable compared to conventional methods. The Portrait Staph
ID/R BCP can identify the most clinically relevant Staphylococcus species that are
increasingly associated with true infections. The decreased time to results has benefits
of improved patient outcomes and promotes antimicrobial stewardship.
MATERIALS AND METHODS
Blood culture specimens. The performance of the FDA-approved Portrait Staph ID/R BCP assay was
determined prospectively at three geographical diverse U.S. clinical sites. Blood cultures were collected
in BD Bactec aerobic (Plus Aerobic/F, Peds Plus/F, and Standard/10 Aerobic/F) and anaerobic (Plus
Anaerobic/F, Lytic/10 Anaerobic/F, and Standard/10 Anaerobic/F) blood culture bottles as part of the
routine standard of care at each facility and incubated on a Bactec FX Instrumented Blood Culture System
(BD Diagnostics, Sparks, MD). Positive Bactec blood culture bottles that contained Gram-positive cocci in
singles or clusters (GPCC) from unique patients were enrolled between December 2014 and May 2015
at Indiana University Health Pathology Laboratory, University of New Mexico/Tricore Laboratories, and
University of Utah, Primary Children’s Medical Center clinical microbiology laboratories. Positive blood
cultures were processed according to routine laboratory procedures at each site. After completion of
clinical processing, 1-ml aliquots of remnant positive blood culture specimens were aseptically removed
from the blood bottle. Specimens were collected within 8 h of positive detection and stored at room
temperature for up to 18 h or refrigerated at 2 to 8°C for up to 72 h before Portrait testing. Two 1-ml
aliquots were frozen at 70°C and sent to the Medical College of Wisconsin laboratory for discordant
testing. Specimens were used in accordance with procedures approved by the Institutional Review Board
at each test site with a waiver for informed consent.
Portrait Staph ID/R BCP assay. The Portrait Staph ID/R BCP assay was performed according to the
manufacturer’s instructions. Briefly, the Portrait Staph ID/R BCP assay is built into an injection-molded
card. Reagents are lyophilized and placed in blister packs. The operator inserts a 50-l aliquot of positive
blood culture broth into the sample port, inserts the card into the PA500 Portrait Analyzer, and presses
the start key to initiate the test. The Portrait system is designed to perform automated sample
preparation, hot-start PCR amplification of specific Staphylococcal DNA detected by hybridization probes
immobilized on a silicon chip. Result options are reported as follows: Staphylococcus aureus  mecA;
Staphylococcus lugdunensis  mecA; Staphylococcus species other than S. aureus or S. lugdunensis 
mecA; S. aureus in mixed Staphylococcus infection (not S. lugdunensis)  mecA; S. lugdunensis in mixed
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Staphylococcus infection (not S. aureus)mecA; S. aureus, S. lugdunensismecA; S. aureus, S. lugdunensis
in mixed infection  mecA; Negative—no Staphylococcus species detected; or Invalid—internal control
failed. The assay is completed in 110 min. Any “No Calls” (invalid or aborted run) results were retested.
Conventional procedures. An aliquot of positive blood was inoculated onto 5% sheep blood agar
and incubated for 48 to 72 h at 35 to 37°C. Staphylococcus isolates were identified using a combination
of biochemical tests catalase, coagulase, and BD Phoenix System (Sparks, MD). Detection of methicillin
resistance was performed using the cefoxitin disk diffusion test according to CLSI guidelines (23).
Data analysis. The performance of the Portrait Staph ID/R BCP assay was compared to a biochemical
method for species identification and to cefoxitin disk diffusion for detection of methicillin resistance.
Discordant identification results were arbitrated by rpoB gene sequencing (24). Discordant resistance
detection results were arbitrated by sequencing of the mecA gene by PCR from single bacterial colonies.
The positive percent agreement (PPA) and negative percent agreement (NPA) of the Portrait Staph ID/R
BCP assay compared to conventional methods were calculated. The 95% confidence intervals (CI) were
determined for performance estimates using results across all three geographical sites.
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